IGF2BP2 and pancreatic ductal adenocarcinoma: In a study of pancreatic ductal adenocarcinoma, lncRNA-PACERR could affect prognosis in patients with pancreatic ductal adenocarcinoma in an m6A-dependent manner by binding to IGF2BP2 27.